Resources

Explore our extensive resources to uncover more about RCA's expertise in life sciences consulting.

Content Type

Segment

Industries

Blogs

Design Controls for Combination Products: The Most Common Compliance Gap

Why Design Controls Matter for Combination Products Design controls represent one of the most significant regulatory challenges for companies entering the combination product market, especially those with a pharmaceutical or...
Read More

Blogs

Avoiding Common 503B GMP Deficiencies: Key Lessons from FDA Warning Letters

503B outsourcing facilities play a critical role in addressing drug shortages and providing large-scale compounded medications. However, with this privilege comes the responsibility of adhering to stringent FDA regulations under...
Read More

Blogs

New FDA Policy Targets Foreign Manufacturers with Unannounced Inspections

On May 6, 2025, the U.S. Food and Drug Administration (FDA) announced it will expand its use of unannounced inspections at foreign manufacturing facilities. This shift is part of the...
Read More

Blogs

Preparing for a successful FDA Inspection as a 503B Facility

FDA inspections are a pivotal moment for any 503B outsourcing facility. Unlike 503A pharmacies, which are primarily state-regulated, 503B facilities are held to Current Good Manufacturing Practices (CGMP) 21 CRF...
Read More

Case Studies

Commercial Readiness Gap Assessment for a Virtual Company

Background A pharmaceutical company preparing for product commercialization faced significant challenges in meeting FDA expectations. The organization lacked standard operating procedures (SOPs), had minimal supplier qualification controls, and was not...
Read More

Case Studies

Remediation & QA System Enhancement

Background A life sciences company preparing for growth and regulatory scrutiny faced major deficiencies in its quality infrastructure. The organization lacked formal quality systems, had no established Quality Control Unit,...
Read More